Zynex Investor Relations Material
Access more data
Zynex, Inc. focuses on the design, manufacture, and marketing of medical devices for the electrotherapy market. It offers NexWave for acute chronic pain management; NeuroMove for activation and exercise of muscles for rehabilitative purposes related to stroke, spinal cord injuries and other neurological disorders; and InWave, an electrical muscle stimulator that treats female urinary incontinence. The company sells its products through distributors in the United States and internationally to hospitals, physical therapy clinics, pain management clinics, home health agencies, long-term care facilities, assisted living facilities, rehabilitation clinics and physician offices. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Key slides for Zynex Inc
Visa and Mastercard: The Global Payment Duopoly
Explore one of the world's largest and most discussed duopolies, from the origins of the credit card to its combined market value of $850 billion.
27 Feb 2024
The Rise of Google, Meta, Amazon, and Youtube in Advertising
Learn about the meteoric rise of digital advertising giants such as Google, Meta, Amazon, and YouTube, and their robust competitive advantages.
1 Mar 2024
Rubrik's 2024 IPO: What Investors Need To Know
Explore Rubrik's journey to a 2024 IPO, its innovative cybersecurity solutions, and strategic growth, highlighting its impact on the tech sector.
29 Feb 2024
🇺🇸 United States